Literature DB >> 8198990

Adjuvant 5-fluorouracil plus levamisole in colon cancer: the plot thickens?

J Cassidy.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8198990      PMCID： PMC1969437          DOI： 10.1038/bjc.1994.193

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  12 in total

Review 1.  Levamisole in the treatment of cancer: anything new? (Review).

Authors:  M De Brabander; J De Crée; J Vandebroek; H Verhaegen; P A Janssen
Journal:  Anticancer Res       Date:  1992 Jan-Feb       Impact factor: 2.480

2.  Multifocal leukoencephalopathy: occurrence during 5-fluorouracil and levamisole therapy and resolution after discontinuation of chemotherapy.

Authors:  D W Kimmel; A J Schutt
Journal:  Mayo Clin Proc       Date:  1993-04       Impact factor: 7.616

Review 3.  Levamisole: known effects on the immune system, clinical results, and future applications to the treatment of cancer.

Authors:  H C Stevenson; I Green; J M Hamilton; B A Calabro; D R Parkinson
Journal:  J Clin Oncol       Date:  1991-11       Impact factor: 44.544

Review 4.  Adjuvant therapy of colorectal cancer. Why we still don't know.

Authors:  M Buyse; A Zeleniuch-Jacquotte; T C Chalmers
Journal:  JAMA       Date:  1988-06-24       Impact factor: 56.272

5.  The benefit of leucovorin-modulated fluorouracil as postoperative adjuvant therapy for primary colon cancer: results from National Surgical Adjuvant Breast and Bowel Project protocol C-03.

Authors:  N Wolmark; H Rockette; B Fisher; D L Wickerham; C Redmond; E R Fisher; J Jones; E P Mamounas; L Ore; N J Petrelli
Journal:  J Clin Oncol       Date:  1993-10       Impact factor: 44.544

6.  Dose-related immunologic effects of levamisole in patients with cancer.

Authors:  J Janik; W C Kopp; J W Smith; D L Longo; W G Alvord; W H Sharfman; R G Fenton; M Sznol; R G Steis; S P Creekmore
Journal:  J Clin Oncol       Date:  1993-01       Impact factor: 44.544

7.  Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma.

Authors:  C G Moertel; T R Fleming; J S Macdonald; D G Haller; J A Laurie; P J Goodman; J S Ungerleider; W A Emerson; D C Tormey; J H Glick
Journal:  N Engl J Med       Date:  1990-02-08       Impact factor: 91.245

8.  Hepatic toxicity associated with fluorouracil plus levamisole adjuvant therapy.

Authors:  C G Moertel; T R Fleming; J S Macdonald; D G Haller; J A Laurie
Journal:  J Clin Oncol       Date:  1993-12       Impact factor: 44.544

9.  Effect of levamisole on major histocompatibility complex class I expression in colorectal and breast carcinoma cell lines.

Authors:  K H Goodrich; X Alvarez; R F Holcombe
Journal:  Cancer       Date:  1993-07-01       Impact factor: 6.860

10.  Late mortality and levamisole adjuvant therapy in colorectal cancer.

Authors:  R T Chlebowski; L Lillington; J S Nystrom; J Sayre
Journal:  Br J Cancer       Date:  1994-06       Impact factor: 7.640
View more
  1 in total

1.  Significant clinical response of advanced colorectal cancer to combination therapy involving capecitabine and adoptive cell transfer therapy: a case report.

Authors:  Shuchun Li; Junjun Ma; Xizhou Hong; Minhua Zheng; Shigenori Goto; Rishu Takimoto; Takashi Kamigaki; Lu Zang
Journal:  Transl Cancer Res       Date:  2019-04       Impact factor: 1.241
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.